Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats

Hepatology

Volumn 25, Issue 4, 1997, Pages 964-969

  Grøfte, Thorbjørn ^a   Wolthers, Troels ^a   Jensen, Søren Astrup ^c   Møller, Niels ^a   Jorgensen J O L ^a   Tygstrup, Niels ^c   Ørskov, Hans ^b   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININOSUCCINATE SYNTHASE; GROWTH HORMONE; MESSENGER RNA; SOMATOMEDIN C;

AMINO ACID METABOLISM; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; LIVER METABOLISM; NITROGEN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; UREA CYCLE;

ANIMALS; ARGININOSUCCINATE SYNTHASE; DRUG SYNERGISM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART; HUMAN GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; LIVER; MUSCLE, SKELETAL; MYOCARDIUM; NITROGEN; RATS; RATS, WISTAR; RNA, MESSENGER; UREA;

EID: 0030914672     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250429     Document Type: Article

References (24)

1. Ward HC, Halliday D, Sim AJ. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987;206:56-61.
2. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990;86:265-272.
3. Snyder DK, Clemmons DR, Underwood LE. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition. J Clin Endocrinol Metab 1988;67:54-61.
4. Manson JM, Wilmore DW. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery 1986;100:188-197.
5. Dahn MS, Lange MP, Jacobs LA. Insulinlike growth factor 1 production is inhibited in human sepsis. Arch Surg 1988;123:1409-1414.
6. Belcher HJ, Mercer D, Judkins KG, Shalaby S, Wise S, Marks V, Tanner NS. Biosynthetic human growth hormone in burned patients: a pilot study [published erratum appears in Burns 1989;15:273]. Burns 1989;15:99-107.
7. Caprio S, Boulware SD, Press M, Sherwin RS, Rubin K, Carpenter TO, Plewe G, et al. Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome. J Pediatr 1992;120:238-243.
8. Clemmons DR, Smith Banks A, Underwood LE. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab 1992;75:234-238.
9. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 1993;91:391-396.
10. Asakawa K, Hizuka N, Takano K, Horikawa R, Sukegawa I, Demura H, Shizume K. Effects of insulin-like growth factor I or human growth hormone in fasted rats. Growth Regul 1992;2:40-44.
11. Pacitti AJ, Inoue Y, Plumley DA, Copeland EM, Souba WW. Growth hormone regulates amino acid transport in human and rat liver. Ann Surg 1992;216:353-361.
12. Palekar AG, Collipp PJ, Maddaiah VT. Growth hormone and rat liver mitochondria: effects on urea cycle enzymes. Biochem Biophys Res Commun 1981;100:1604-1610.
13. Wolthers T, Grofte T, Jorgensen JO, Moller N, Vahl N, Christiansen JS, Vilstrup H. Effects of growth hormone (GH) administration on functional hepatic nitrogen clearance: studies in normal subjects and GH-deficient patients. J Clin Endocrinol Metab 1994;78:1220-1224.
14. 3) administration on functional hepatic nitrogen clearance in normal man. J Hepatol 1996;24:313-319.
15. Hansen BA, Vilstrup H. A method for determination of the capacity of urea synthesis in the rat. Scand J Clin Lab Invest 1985;45:315-320.
16. Cerdan S, Lusty CJ, Davis KM, Jacobsohn JA, Williamson JR. Role of calcium as an inhibitor of rat liver carbamylphosphate synthetase I. J Biol Chem 1984;259:323-331.
17. McIntyre P, Mercer JF, Peterson MG, Hudson P, Hoogenraad N. Selection of a cDNA clone which contains the complete coding sequence for the mature form of ornithine transcarbamylase from rat liver: expression of the cloned protein in Escherichia coli. Molecular cloning of rat ornithine transcarbamylase. Eur J Biochem 1984;143:183-187.
18. Surh LC, Morris SM, O'Brien WE, Beaudet AL. Nucleotide sequence of the cDNA encoding the rat argininosuccinate synthetase. Nucleic Acids Res 1988;16:9352.
19. Amaya Y, Matsubasa T, Takiguchi M, Kobayashi K, Saheki T, Kawamoto S, Mon M. Amino acid sequence of rat argininosuccinate lyase deduced from cDNA. J Biochem Tokyo 1988;103:177-181.
20. Dizikes GJ, Specter EB, Cederbaum SD. Cloning of rat liver arginase cDNA and elucidation of regulation of arginase gene expression in H4 rat hepatoma cells. Somat Cell Mol Genet 1986;12:375-384.
21. Henriksen EJ, Bourey RE, Rodnick KJ, Koranyi L, Permutt MA, Holloszy JO. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol 1990;259:E593-E598.
22. Almdal TP, Petersen KF, Hansen BA, Vilstrup H. Increased capacity of urea synthesis in streptozotocin diabetes in rats [published erratum appears in Diabetologia 1987;30:49]. Diabetologia 1986;29:812-816.
23. Fawcett JK, Scott JE. A rapid and precise method for determination of urea. J Clin Pathol 1960;13:156-159.
24. Goodwin JF. Spectrophotometric quantitation of plasma and urinary amino nitrogen with fluorid. Stand Meth Clin Chem 1970;6:89-98.